Serum superoxide dismutase activity: a sensitive, convenient, and economical indicator associated with the prevalence of chronic type 2 diabetic complications, especially in men
Open Access
- 4 March 2021
- journal article
- research article
- Published by Taylor & Francis in Free Radical Research
- Vol. 55 (3) , 275-281
Abstract
To investigate the relationship between serum superoxide dismutase (SOD) activity and the presence of chronic complications in patients with type 2 diabetes mellitus (T2DM). We conducted a retrospective cross-sectional study in patients with T2DM. They were assigned to three groups (Q1, Q2, and Q3) by SOD levels in both sexes. Clinical characteristics, cardiovascular disease, diabetic retinopathy, nephropathy, and peripheral neuropathy were compared. The relationship between the SOD and the prevalence of chronic complications was analyzed by binary logistic regression. Statistical analysis was performed in SPSS 26.0. A total of 645 T2DM patients (401 men and 244 women) with complete data for SOD and medical records of complications were included. In men, patients in the Q1 group (lowest serum SOD activity) had the highest prevalence of diabetes with atherosclerosis (P < 0.001), DN (P = 0.029), and DPN (P = 0.001). In comparison, only DN was found to have the highest prevalence in the Q1 group in women (P = 0.010). In the multivariate analysis, patients in the Q1 group had a 3.0-, 1.6-, 1.9-, and 2.4-fold risk for the prevalence of atherosclerosis, DR, DN, and DPN, respectively, compared with the Q3 group. In women, a 7.0-fold risk for the prevalence of DN in the Q1 group was found compared with the Q3 group. After adjusting for the age, duration of T2DM, body mass index, pulse pressure, alanine transaminase, clearance of creatinine, triglyceride, glycosylated hemoglobin, and fasting C-peptide in the models, the differences found in both men and women persisted. SOD activity is related to cardiovascular and microvascular diseases in men and the prevalence of diabetic nephropathy in women in T2DM.Keywords
This publication has 25 references indexed in Scilit:
- Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathwayNeural Regeneration Research, 2016
- Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic PatientsOxidative Medicine and Cellular Longevity, 2015
- Predictive Factors of follow-up Non-attendance and Mortality Among Adults with Type 2 Diabetes Mellitus- an Analysis of the Malaysian Diabetes Registry 2009Current Diabetes Reviews, 2015
- New insights of superoxide dismutase inhibition of pyrogallol autoxidationMolecular and Cellular Biochemistry, 2014
- Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal womenClimacteric, 2014
- Economic Costs of Diabetes in the U.S. in 2012Diabetes Care, 2013
- Extracellular superoxide dismutase regulates cardiac function and fibrosisJournal of Molecular and Cellular Cardiology, 2009
- Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempolMetabolism, 2007
- Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stressFree Radical Biology and Medicine, 2006
- Role of Mitochondrial Superoxide Dismutase in the Development of Diabetic RetinopathyInvestigative Ophthalmology & Visual Science, 2006